Dose Flexibility, Personalized Medicine, and Compounding Florida SB 860: A Direct Threat to Compounded GLP-1s Why Florida Compounding Impacts the Entire Country Why Obesity Medications Are Being Singled Out Active Pharmaceutical Ingredients (API): What Patients Should Know FDA Oversight, the Green List, and State Overreach Why Floridas API & COA Requirements Dont Add Up FDA Inspection Backlogs & Impossible Compliance Standards Branded Drug Safety Issues vs Compounding Scrutiny Catalent, Novo Nordisk, and Manufacturing Concerns Counterfeit Ozempic: The Overlooked Safety Crisis Why Supply Chain Integrity Should Be the Priority What Patients Can Do Right Now Petitions, Advocacy, and Making Your Voice Heard Florida Residents: Why Local Action Matters Final Thoughts on Access, Power, and Patient Advocacy Visit Our Sponsors
We were excited for a new start in Northern California, with farmers markets and year-round sunshine and biking and hiking trails
The FDA and state boards of pharmacy regulate compounding mainly categorized into two categories, 503A and 503B facilities
Quick math example A 10 mg vial mixed with 2 mL gives 5 mg/mL, or 5,000 mcg/mL
That raises the question: What happens to peoples health after they stop taking these medications
Najafi, S., Bahrami, M., Butler, A